Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19

NCT04359953 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped difficulty in recruiting

Conditions

COVID-19 Infection

Interventions

DRUG: Hydroxychloroquine
DRUG: Azithromycin
DRUG: Telmisartan

Sponsor

University Hospital, Strasbourg, France